N-butylphthalide (NBP) and ligustrazine (TMP) triazole hybrids target the KEAP1-NRF2 pathway to inhibit ferroptosis and exert brain neuroprotectivity
Ischemic stroke is a life-threatening disease, its pathological progression involves multiple factors, including oxidative stress, apoptosis, and ferroptosis. Our previous study demonstrated that hybridizing N-butylphthalide (NBP) with ligustrazine (TMP) yielded promising anti-ischemic compounds. In...
Saved in:
| Main Authors: | Guangyu Li, Haiyan Xiao, Chenwei Zuo, Haochen Xie, Xiaolin Wang, Jiaxin Wang, Ying Liu, Quanxing Hou, Guibo Sun, Yu Tian |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Series: | Redox Biology |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2213231725003489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dl-3-n-butylphthalide attenuates DOX-induced cardiotoxicity in mice by inhibiting Nrf2/Keap1 complex formation
by: Yixiao Yan, et al.
Published: (2025-04-01) -
The inhibitory and anti-inflammatory effects of TMP269 on peste des petits ruminants virus replication
by: Miaomiao Li, et al.
Published: (2025-12-01) -
NBP Monetary Policy in 2020–2022 in the Light of Central Banks' Responses to External Shocks
by: Kamila Szmigiel
Published: (2025-06-01) -
Caspofungin Combined With TMP/SMZ in Treatment of Intractable Acute Pneumocystis jirovecii Pneumonia in Renal Transplant Recipients: Case Report and Literature Review
by: Hongtao Hu, et al.
Published: (2025-08-01) -
Repurposing of epalrestat for neuroprotection in parkinson’s disease via activation of the KEAP1/Nrf2 pathway
by: Huafang Jia, et al.
Published: (2025-04-01)